secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001437749-23-017306
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key cures Nasdaq listing deficiencies; all periodic reports now timely filed
--------------------------------------------------------------------------------

- Nasdaq notified BIO-key on June 13, 2023 that it is in compliance with Listing Rule 5250(c)(1).
- Company had received deficiency notices for failure to timely file Form 10-K (year ended Dec 31, 2022) and Form 10-Q (quarter ended Mar 31, 2023).
- Form 10-K was filed on June 1, 2023; Form 10-Q was filed on June 9, 2023, curing both deficiencies.
- Previously closed Form 10-K matter and newly closed Form 10-Q matter remove all pending delisting risks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923017306/0001437749-23-017306-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923017306/bkyi20230613_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-017306

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer